ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial | VuMedi

Find latest Head & Neck videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial

By 2024 ESMO Annual Meeting Insights Hub FEATURING Makoto Tahara

By 2024 ESMO Annual Meeting Insights Hub FEATURING Makoto Tahara

178 views

September 20, 2024

Comments 0

Login to view comments. Click here to Login